Publication | Closed Access

Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer

VaccinationMedicineVaccine TargetImmunologyPathologyVirologyColorectal CancerTherapeutic VaccineCarcinoembryonic AntigenRecombinant Vaccinia VirusAdvanced Colorectal CancerImmunotherapyOncologyRadiation OncologyCancer ResearchViral OncologyCancer-associated Virus